Insurer Enablement MediGence offers a ready-to-deploy Care Control Pathway platform that allows insurers to launch and govern International Healthcare Programmes under their own brand with full data visibility, potentially enabling B2B sales to insurance carriers, HMOs, and medical aid societies seeking control and transparency in cross-border care.

End-to-End Case Management In addition to CCP, MediGence provides MVT the managed-service offering for end-to-end international case management. This creates an upsell opportunity with insurers seeking turnkey solutions without platform deployment, appealing to claims, medical, or commercial strategy leaders.

Global Network With 500+ hospital partnerships, 5,000+ doctors, and 100,000+ patient journeys across 20+ countries, MediGence can position as a trusted gateway for insurers expanding international treatment access, enabling co-branding and premium service tiers.

Compliance Advantage CCP operates within a JCI- and NABH-aligned clinical framework and centers on pre-approval clinical validation, risk assessment, and cost benchmarking. This compliance and diligence angle can be sold to insurers prioritizing risk mitigation and quality assurance in international care.

Rapid Deployment and Customization CCP deploys in seven days and is highly configurable to an insurer’s existing book, corporate clients, and regional footprint, creating a fast time-to-value pitch for sales teams targeting insurers with mixed portfolios and diverse geographies.